Enovis Corporation (ENOV) vs PROCEPT BioRobotics Corporation (PRCT)
Enovis Corporation and PROCEPT BioRobotics Corporation are both Medical Devices companies. Enovis Corporation and PROCEPT BioRobotics Corporation are of similar size ($1.1B and $1.0B). PROCEPT BioRobotics Corporation grew revenue faster over the last twelve months: 22.7% against 4.89%. PROCEPT BioRobotics Corporation has the higher net margin (−32.5% vs −48.0%) and the lower return on invested capital (−43.6% vs −23.6%). Across the 18 metrics below, PROCEPT BioRobotics Corporation leads on 12 and Enovis Corporation on 6.
Valuation
Profitability
| Metric | ENOV | PRCT | Medical Devices median |
|---|---|---|---|
| Gross margin | 61.09% | 64.22% | 56.01% |
| Operating margin | (45.14%) | (33.86%) | (15.03%) |
| Net margin | (47.97%) | (32.54%) | (20.40%) |
| Free cash flow margin | 2.77% | (25.17%) | (7.24%) |
| Return on equity | (54.27%) | (30.24%) | (15.32%) |
| Return on assets | (25.07%) | (22.12%) | (19.72%) |
| Return on invested capital | (23.55%) | (43.57%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack